MARKET WIREYahoo Finance • 8h ago
Smith+Nephew Launches CARTIHEAL Implant Across Key European MarketsYahoo Finance report covering Smith & Nephew SNATS Inc. (SNN) market action, institutional positioning, and fundamental catalysts.
Why SNN Stock dropped -2.33% Today — RQD Quant Desk Flash
$29.70 -2.33% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $29.52
Smith & Nephew SNATS Inc. (SNN) carries a Roarable Rating of D+ (Sell) with 58/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D+ • SELL / AVOID
Cap $12.73B
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on SNN Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is SNN stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-02, Smith & Nephew SNATS Inc. (NYSE: SNN) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 58/100 at a spot price of $29.70 (-2.33% 1D, market cap $12.73B). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 16/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 12/20. Across 1016 tracked Health Care issuers, SNN ranks #194 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does SNN compare to ALGN and ZBH in the Health Care sector?
▼
Within the Health Care sector (Industrial Specialties), SNN carries a Roarable D+ (58/100 RQD), trailing P/E of 32.8x, gross margin of —, and ROIC of 9.9%. By comparison, ALGN (Align Technology Inc.) holds a C+ grade (66/100 RQD, P/E 26.6x, ROIC 11.1%, cap $10.92B) and ZBH (Zimmer Biomet Holdings Inc.) posts a B- grade (71/100 RQD, P/E 26.4x, ROIC 4.6%, cap $18.59B). Among the 5-stock peer group, MSA leads on earnings multiple (24.8x) while MSA leads on capital efficiency (16.6% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for SNN?
▼
For Smith & Nephew SNATS Inc. (SNN), key quantitative strengths include Clean SEC annual filing review with no major hidden accounting time-bombs. and sector rank #194 in Health Care, while primary risk factors center on Sensitive to high interest rates and tighter Federal Reserve market liquidity. and implied 5-year growth hurdle of 25.3%/yr. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $29.52 (-0.61%)🧬 Cannibal Buyback (-1.24% YoY Shares)⚙️ Cash Engine: 11/20 (D+) • 7% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record: Scores of 58/100 (D+) historically posted market-perform odds over rolling 90-day windows (+0.0% avg 90D alpha vs SPY • 52.7% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →RQD QUANT TACHOMETERSELL / AVOID • D+
JEV AI Jury Split (Battleground)
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D+ · Rk C-
Each axis scored 0–20
12M PRICE TARGET CONE+0% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for SNN)Realized 20D OHLCV Swing Band: ±3.3%
Deterministic 5-Pillar Attribution (58/100 Composite)
🔍 WHY SNN SCORES 58/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+16/20 pts (28% of score)
Altman Z-Score 3.74 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 8/9
▲ #2 Bullish Driver: Insider Conviction & Share Dilution+12/20 pts (21% of score)
SEC Form 4 / 13F Thermometer: 60% Net Buy • Cannibal Buyback (-1.24% YoY Shares)
▼ #1 Drag / Risk Factor: Macro Regime Fit8/20 pts (-12 pt drag)
Macro rate sensitivity & RSI-14 (63.6) create a -12 pt regime headwind
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade C-$27.86+5.2% Next Q
50
Q2 (-2Q)Grade C-$29.32+2.7% Next Q
53
Q3 (-1Q)Grade C$30.10-1.3% Next Q
55
CurrentGrade D+$29.70+0% Hist 90D α
58
Trajectory: C- (50) → D+ (58)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER
⚔️ Adversarial Opposing Case: Why the SNN Bull Thesis Could Fail
Even with a 58/100 (D+) score, SNN faces multiple-compression risk if 32.8x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
⚠️ Forensic Kill-Switch #1
Sensitive to high interest rates and tighter Federal Reserve market liquidity.
⚠️ Forensic Kill-Switch #2
Dilution & Margin Drag: Cannibal Buyback (-1.24% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.
⚠️ Forensic Kill-Switch #3
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($28.35) or 200D SMA ($31.04) invalidates the momentum regime and cuts Target Base ($29.70) toward Bear Floor ($23.17).
🎲 LIVE PREDICTION MARKET ODDS TIED TO $SNN• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “SNN Beats Next Quarter EPS Consensus (Upcoming Quarter) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why SNN Stock dropped -2.33% Today — RQD Quant Desk Flash
Smith & Nephew SNATS Inc. (SNN) dropped -2.33% to $29.70, trading at 33% of its 52-week range ($26.12 – $37.09). Stretched risk/reward at 33x P/E (10% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 33% of its 52-week range ($26.12 – $37.09) with RSI-14 at 63.6 (BULLISH MOMENTUM).
- ▸Volatility Profile: Historical 20-day realized swing band of ±3.3% around $29.70 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D+ (Sell) backed by 52% gross margin and $281.4M annual free cash flow.
Live SNN Headlines & Catalysts
RISK WATCHStock Traders Daily • 11h ago
Discipline and Rules-Based Execution in SNN ResponseStock Traders Daily report covering Smith & Nephew SNATS Inc. (SNN) market action, institutional positioning, and fundamental catalysts.
MARKET WIREhttps://www.dars.gov.et/ • 14h ago
Smith & Nephew (SNN) Holds Near $30.83 as Traders Eye Support at $29.29 - Up Down Volumehttps://www.dars.gov.et/ report covering Smith & Nephew SNATS Inc. (SNN) market action, institutional positioning, and fundamental catalysts.
MARKET WIREMarketBeat • 17h ago
Top Teleflex (TFX) Competitors 2026MarketBeat report covering Smith & Nephew SNATS Inc. (SNN) market action, institutional positioning, and fundamental catalysts.
CATALYSTwww.siam.in • 20h ago
After +2.19% Gain, Is Smith (SNN) Still a Value Play? 2026-10-22 - Tick Indexwww.siam.in report covering Smith & Nephew SNATS Inc. (SNN) market action, institutional positioning, and fundamental catalysts.
MARKET WIREad-hoc-news.de • 23h ago
Smith & Nephew stock steadies as new USD 700 million bond reshapes its debt profilead-hoc-news.de report covering Smith & Nephew SNATS Inc. (SNN) market action, institutional positioning, and fundamental catalysts.
MARKET WIREStock Traders Daily • 1d ago
(SNN) and the Role of Price-Sensitive AllocationsStock Traders Daily report covering Smith & Nephew SNATS Inc. (SNN) market action, institutional positioning, and fundamental catalysts.
MARKET WIREMarketBeat • 1d ago
Top MiniMed Group (MMED) Competitors 2026MarketBeat report covering Smith & Nephew SNATS Inc. (SNN) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo • 4d ago
3 British Undervalued Stocks To Own In October 2026Oil prices are back in focus after Europe’s monthly petroleum bill rose by €10b compared with 2025, and higher fuel costs are feeding through to household and business budgets. When broad markets fixate on expensive ener
MARKET WIREYahoo • 7d ago
What Do Johnson & Johnson (JNJ) Cancer Trial Wins Mean For Its Stock?Johnson & Johnson (NYSE: JNJ) reported new oncology data, including a 75% tumor response rate for JNJ-6143 in advanced prostate cancer. The RYBREVANT FASPRO regimen produced a 77% response rate as an initial treatment op
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring SNN)
- ✓Walkthrough of SNN's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
SNN // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -3.88%📐 HORIZONTAL RANGE
2026-11-02O $30.12H $30.41L $29.70C $29.70VOL 1.57M
RES: $31.33SUP: $24.62SMA50: $28.35SMA200: $31.04
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
SNN Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
25.3%/yr Implied 5Y Growth
vs. +6.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on SNN today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for SNN. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for SNN today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (SNN)
Health Care Rank #194 of 1016
⚔️ ALGN vs SNN Full Matrix →
1. Head-to-Head Health Care Peer Comparison (SNN vs. ALGN, ZBH, STE, MSA)
Industry: Industrial Specialties (55 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Smith & Nephew SNATS Inc. (SNN) ranks #194 by composite RQD confidence (58/100, grade D+) and #89 by equity capitalization ($12.73B). Within this direct 5-issuer industry benchmark cohort, MSA leads on earnings valuation at 24.8x trailing P/E, while MSA leads on capital efficiency and profitability with 16.6% ROIC and 46.5% gross margin. STE currently holds the highest overall quantitative score in the immediate peer group at 72/100 (B) compared with SNN at 58/100 (D+).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| SNN
ACTIVE
Smith & Nephew SNATS Inc. | D+ | 58/100 | 32.8x | — | 9.9% | -2.33% | $12.73B | Benchmark Subject |
| ALGN Align Technology Inc. | C+ | 66/100 | 26.6x | 67.2% | 11.1% | -2.48% | $10.92B | /algn-vs-snn → |
| ZBH Zimmer Biomet Holdings Inc. | B- | 71/100 | 26.4x | 69.7% | 4.6% | -3.03% | $18.59B | /zbh-vs-snn → |
| STE STERIS plc (Ireland) | B | 72/100 | 28.9x | 44.2% | 10.1% | -2.16% | $22.63B | /ste-vs-snn → |
| MSA MSA Safety Incorporated | B | 72/100 | 24.8x | 46.5% | 16.6% | -0.33% | $6.91B | /msa-vs-snn → |
2. SNN Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics
TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOTSmith & Nephew SNATS Inc. (SNN) operates in Industrial Specialties (Health Care) with an equity capitalization of $12.73B, trailing P/E of 32.8x, forward P/E of 30.5x, and EV/EBITDA of 21.0x. Operating profitability registers a gross margin of —, operating margin of 13.9%, net profit margin of 10.9%, ROIC of 9.9%, and free cash flow yield of 2.21%, alongside an Altman Z-Score of 3.74 and Piotroski F-Score of 8/9.
3. SNN Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs SNN stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-02, Smith & Nephew SNATS Inc. (NYSE: SNN) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 58/100 at a spot price of $29.70 (-2.33% 1D, market cap $12.73B). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 16/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 12/20. Across 1016 tracked Health Care issuers, SNN ranks #194 in composite RQD confidence.
How does SNN compare to ALGN and ZBH in the Health Care sector?
Within the Health Care sector (Industrial Specialties), SNN carries a Roarable D+ (58/100 RQD), trailing P/E of 32.8x, gross margin of —, and ROIC of 9.9%. By comparison, ALGN (Align Technology Inc.) holds a C+ grade (66/100 RQD, P/E 26.6x, ROIC 11.1%, cap $10.92B) and ZBH (Zimmer Biomet Holdings Inc.) posts a B- grade (71/100 RQD, P/E 26.4x, ROIC 4.6%, cap $18.59B). Among the 5-stock peer group, MSA leads on earnings multiple (24.8x) while MSA leads on capital efficiency (16.6% ROIC).
What are the biggest fundamental strengths and SEC risk factors for SNN?
For Smith & Nephew SNATS Inc. (SNN), key quantitative strengths include Clean SEC annual filing review with no major hidden accounting time-bombs. and sector rank #194 in Health Care, while primary risk factors center on Sensitive to high interest rates and tighter Federal Reserve market liquidity. and implied 5-year growth hurdle of 25.3%/yr. Institutional options positioning shows a 50% call / 50% put premium split.
Where is SNN trading relative to its 50-day, 200-day, and 52-week technical levels?
SNN last traded at $29.70 (-2.33% on volume of 1,730,165 shares), positioning the stock +4.76% above its 50-day simple moving average ($28.35) and -4.32% below its 200-day simple moving average ($31.04). Across its 52-week range of $26.12 to $37.09, SNN sits at the 32.6% percentile with a 14-day RSI of 63.6 (BULLISH MOMENTUM) and an implied next-earnings move of ±3.3% ($28.72 to $30.68).
SNN Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is SNN stock moving today?
Why SNN Stock dropped -2.33% Today — RQD Quant Desk Flash. Stretched risk/reward at 33x P/E (10% return on capital) under elevated 10-year interest-rate pressure.
ROARABLE RATING BRIEF • RQD 58/100 (D+)
✓ STAGE-C NUMBER FIREWALL VERIFIED
SNN — Smith & Nephew SNATS Inc.: What the Facts Mean to a Prospective Investor
Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T14:10:08Z
Roarable Rating Brief: What This Means to a Prospective Investor
Per the Roarable RQD rating, SNN scores 58 out of 100, graded D+, with the verdict "Roarable Sell — Weak Fundamentals / Trim." The five pillars are: Fundamental Cash Engine at 11 / 20 (ROIC 9.9%; FCF yield 2.21%), Whale 13F Flow at 11 / 20 (institutional accumulation and options positioning), Insider Conviction at 12 / 20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit at 8 / 20 (Beta 1.03; sector sensitivity), and Forensic Balance Sheet at 16 / 20 (Altman Z 3.74; Piotroski F 8/9; Debt/Equity 0.39). The strongest pillar is the forensic balance sheet, which indicates low measured balance-sheet risk. The weakest are macro regime fit and the cash engine: the rating's own inputs show a modest ROIC and a thin free-cash-flow yield relative to a P/E (TTM) of 32.8, meaning the valuation leaves limited cushion if cash generation does not expand. Insider and institutional pillars are mid-range and do not offer a clear counterweight in the supplied data. For a prospective investor, the evidence points to a financially sound issuer priced at a premium multiple, where upside depends on earnings and cash-flow growth that the rating does not confirm. This is an analytical summary of the rating's components, not personalized financial advice.
Snapshot
Recent Catalysts & News Wire Analysis
Per the recent news section, six items were reported, with signal labels as follows:
- CATALYST (GREEN): a report covering SNN market action, institutional positioning, and fundamental catalysts.
- RISK WATCH (RED): a report titled around disciplined, rules-based execution in response to SNN.
- MARKET WIRE (YELLOW): four items, covering a CARTIHEAL implant launch across European markets, a technical-level price report referencing $30.83 and $29.29, a competitor listing for Teleflex, and a report on a new USD 700 million bond reshaping the debt profile.
The bond item is the most fundamentally relevant headline, since it bears on the balance-sheet pillar, but the headline alone does not state terms, maturities, or use of proceeds. Several items have weak source attribution (one labeled with a government domain, one with a generic site name), so they should be treated as unverified. Per the Butterfly Supply-Chain Graph, no supply-chain links or proprietary signals are recorded.
Open Questions
- What are the company's revenue, operating income, net income, and free cash flow across reported periods? The financials section is empty, so the earnings trajectory behind the 32.8 TTM P/E cannot be verified.
- What are the terms, maturity, and use of proceeds for the reported USD 700 million bond, and how does it change leverage?
- Why is gross margin reported as 0%, and is that a data gap or an accounting presentation issue?
- What is the consensus analyst rating and price target, given that the analyst section is empty?
- Who are the institutional and insider holders, and what is the direction of their recent activity, given that the holders section is empty?
SNN Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Smith & Nephew SNATS Inc. (SNN) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE Yahoo Finance • 8h ago
Smith+Nephew Launches CARTIHEAL Implant Across Key European Markets Yahoo Finance report covering Smith & Nephew SNATS Inc. (SNN) market action, institutional positioning, and fundamental catalysts.
🔴 RISK WATCH Stock Traders Daily • 11h ago
Discipline and Rules-Based Execution in SNN Response Stock Traders Daily report covering Smith & Nephew SNATS Inc. (SNN) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE https://www.dars.gov.et/ • 14h ago
Smith & Nephew (SNN) Holds Near $30.83 as Traders Eye Support at $29.29 - Up Down Volume https://www.dars.gov.et/ report covering Smith & Nephew SNATS Inc. (SNN) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE MarketBeat • 17h ago
Top Teleflex (TFX) Competitors 2026 MarketBeat report covering Smith & Nephew SNATS Inc. (SNN) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST www.siam.in • 20h ago
After +2.19% Gain, Is Smith (SNN) Still a Value Play? 2026-10-22 - Tick Index www.siam.in report covering Smith & Nephew SNATS Inc. (SNN) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE ad-hoc-news.de • 23h ago
Smith & Nephew stock steadies as new USD 700 million bond reshapes its debt profile ad-hoc-news.de report covering Smith & Nephew SNATS Inc. (SNN) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Stock Traders Daily • 1d ago
(SNN) and the Role of Price-Sensitive Allocations Stock Traders Daily report covering Smith & Nephew SNATS Inc. (SNN) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE MarketBeat • 1d ago
Top MiniMed Group (MMED) Competitors 2026 MarketBeat report covering Smith & Nephew SNATS Inc. (SNN) market action, institutional positioning, and fundamental catalysts.
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
SNN Bull vs. Bear Conversation Board — What's Your Call at $29.70?
🐂 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON SNN 🐻 50% BEARISH CONVICTION
RO RoarDesk_Moderator Roarable Research Desk ⚖️ DEBATE HOST
🎯 Target: $32.84 (+8.0%)
📌 Pinned Debate 🔥 Official Bull vs. Bear Debate: Is SNN (D+ • RQD 58/100) a Buy at $30.41?
Welcome to the SNN (Smith & Nephew SNATS Inc.) Roar Pit. Current RQD Composite is 58/100 (Roarable Sell — Weak Fundamentals / Trim) in Industrial Specialties. Bulls point to operating leverage and sector positioning, while bears focus on valuation multiple compression (32.8x trailing P/E). Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
BE BearTrap_Alert Forensic Accounting Watch 🐻 BEARISH
🎯 Target: $25.24 (-17.0%)
Spot @ $30.41 Pump the brakes on SNN — check the valuation vs. margin headwinds
Everyone in here is repeating the bull case on SNN, but look at what you are paying: 32.8x trailing P/E with tightening sector spreads. Unless Smith & Nephew SNATS Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
QU QuantViper Verified K Arena Trader 🐂 BULLISH
🎯 Target: $34.97 (+15.0%)
Spot @ $30.41 SNN cash flow & RQD setup is being underpriced by the Street here
Looking at the 5-pillar RQD breakdown on SNN, the market is fixating on short-term headline noise in Industrial Specialties and ignoring the balance sheet and cash flow trajectory. At $30.41 (52-wk range $26.12 - $37.09), any beat on forward guidance forces shorts and underweight funds to chase.